See more : Tazmo Co., Ltd. (6266.T) Income Statement Analysis – Financial Results
Complete financial analysis of The Pennant Group, Inc. (PNTG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Pennant Group, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- PepGen Inc. (PEPG) Income Statement Analysis – Financial Results
- Nova Minerals Limited (NVAWW) Income Statement Analysis – Financial Results
- Reinvent Technology Partners Y (RTPY) Income Statement Analysis – Financial Results
- Zhejiang Wansheng Co., Ltd. (603010.SS) Income Statement Analysis – Financial Results
- ClearStory Systems, Inc. (CSYS) Income Statement Analysis – Financial Results
The Pennant Group, Inc. (PNTG)
About The Pennant Group, Inc.
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support. As of December 31, 2021, the company operated 88 home health and hospice agencies, and 54 senior living communities with 4127 Senior Living units in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 544.89M | 473.24M | 439.69M | 390.95M | 338.53M | 286.06M | 250.99M | 217.23M |
| Cost of Revenue | 477.86M | 414.66M | 393.96M | 336.07M | 293.92M | 243.62M | 218.58M | 188.94M |
| Gross Profit | 67.04M | 58.59M | 45.74M | 54.89M | 44.62M | 42.44M | 32.41M | 28.29M |
| Gross Profit Ratio | 12.30% | 12.38% | 10.40% | 14.04% | 13.18% | 14.84% | 12.91% | 13.02% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 36.67M | 33.98M | 36.26M | 31.30M | 35.14M | 18.84M | 14.46M | 12.45M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 36.67M | 33.98M | 36.26M | 31.30M | 35.14M | 18.84M | 14.46M | 12.45M |
| Other Expenses | 0.00 | 4.90M | 4.78M | 4.68M | 3.81M | 2.96M | 2.54M | 2.86M |
| Operating Expenses | 41.87M | 38.88M | 41.04M | 35.97M | 38.95M | 21.81M | 17.01M | 15.30M |
| Cost & Expenses | 519.72M | 453.54M | 435.00M | 372.04M | 332.86M | 265.43M | 235.59M | 204.24M |
| Interest Income | 0.00 | 3.82M | 1.94M | 1.24M | 410.00K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 5.92M | 3.82M | 1.94M | 1.24M | 410.00K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 5.13M | 4.90M | 4.78M | 4.68M | 4.03M | 2.96M | 2.54M | 2.86M |
| EBITDA | 30.64M | 24.60M | 9.46M | 23.82M | 9.48M | 23.60M | 17.95M | 15.84M |
| EBITDA Ratio | 5.62% | 5.19% | 2.15% | 6.09% | 2.80% | 8.25% | 7.15% | 7.29% |
| Operating Income | 25.17M | 19.67M | 4.70M | 18.92M | 5.67M | 20.63M | 15.40M | 12.98M |
| Operating Income Ratio | 4.62% | 4.16% | 1.07% | 4.84% | 1.67% | 7.21% | 6.14% | 5.98% |
| Total Other Income/Expenses | -5.59M | -3.85M | -1.97M | -1.01M | -410.00K | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 19.58M | 8.89M | 2.73M | 17.90M | 5.26M | 20.63M | 15.40M | 12.98M |
| Income Before Tax Ratio | 3.59% | 1.88% | 0.62% | 4.58% | 1.55% | 7.21% | 6.14% | 5.98% |
| Income Tax Expense | 5.67M | 1.65M | 582.00K | 2.35M | 2.09M | 4.35M | 5.38M | 5.07M |
| Net Income | 13.38M | 6.64M | 2.15M | 15.74M | 2.55M | 15.68M | 9.87M | 7.89M |
| Net Income Ratio | 2.46% | 1.40% | 0.49% | 4.03% | 0.75% | 5.48% | 3.93% | 3.63% |
| EPS | 0.45 | 0.23 | 0.08 | 0.56 | 0.09 | 0.56 | 0.35 | 0.28 |
| EPS Diluted | 0.44 | 0.22 | 0.07 | 0.52 | 0.09 | 0.56 | 0.35 | 0.28 |
| Weighted Avg Shares Out | 29.86M | 29.06M | 28.41M | 28.03M | 27.84M | 27.83M | 27.83M | 28.00M |
| Weighted Avg Shares Out (Dil) | 30.19M | 30.16M | 30.64M | 30.23M | 29.59M | 28.00M | 28.00M | 28.00M |
The Pennant Group, Inc. (PNTG) Now Trades Above Golden Cross: Time to Buy?
Are Investors Undervaluing The Pennant Group (PNTG) Right Now?
The Pennant Group, Inc. (PNTG) Shows Fast-paced Momentum But Is Still a Bargain Stock
Pennant Acquires Yuma Arizona Hospice Provider
4 Stocks to Watch in an Evolving Outpatient Home Health Industry
Should Value Investors Buy The Pennant Group (PNTG) Stock?
Fast-paced Momentum Stock The Pennant Group, Inc. (PNTG) Is Still Trading at a Bargain
Pennant Group, Inc. (PNTG) Q3 2023 Earnings Call Transcript
Here's What Key Metrics Tell Us About The Pennant Group, Inc. (PNTG) Q3 Earnings
Pennant Acquires Northern Texas and Southern Oklahoma Hospice Provider
Source: https://incomestatements.info
Category: Stock Reports